149 related articles for article (PubMed ID: 7087975)
1. [Continuous subcutaneous desferrioxamine infusions in patients with hemosiderosis (author's transl)].
Tillmann W; König R; Schröder K; Schröter W
Monatsschr Kinderheilkd; 1982 Mar; 130(3):171-2. PubMed ID: 7087975
[No Abstract] [Full Text] [Related]
2. [Continuous subcutaneous deferoxamine treatment in thalassemia major. Decrease of hemosiderosis and improvement of liver function].
Krüger N; Ullrich D; Tillmann W; Schröter W
Dtsch Med Wochenschr; 1985 Nov; 110(48):1848-51. PubMed ID: 4064938
[TBL] [Abstract][Full Text] [Related]
3. [Continuous subcutaneous deferoxamine infusions in thalassemia major. Improvement in glucose tolerance].
Krüger N; Stubbe P; Tillmann W; Schröter W
Dtsch Med Wochenschr; 1986 May; 111(18):698-701. PubMed ID: 3486106
[TBL] [Abstract][Full Text] [Related]
4. [Deferoxamine in hemosiderosis. Fecal iron excretion during continuous subcutaneous infusion].
Krüger N; Kijewski H; König R; Tillmann W; Schröter W
Dtsch Med Wochenschr; 1984 Nov; 109(44):1682-5. PubMed ID: 6489181
[TBL] [Abstract][Full Text] [Related]
5. Congenital erythroblastic hypoplasia. Treatment of transfusion hemosiderosis with desferrioxamine B.
Hildner FJ; Monto RW; Rebuck JW
Henry Ford Hosp Med J; 1968; 16(2):147-55. PubMed ID: 5650037
[No Abstract] [Full Text] [Related]
6. Evaluation of continuous desferrioxamine administration in adults with transfusional hemosiderosis.
Cooper B; Bunn HF; Propper RD; Nathan DG; Rosenthal DS; Moloney WC
Trans Assoc Am Physicians; 1977; 90():335-41. PubMed ID: 611665
[No Abstract] [Full Text] [Related]
7. Iron chelating therapy in thalassemia: current problems.
Russo G
Haematologica; 1990; 75 Suppl 5():84-8. PubMed ID: 2086385
[No Abstract] [Full Text] [Related]
8. [Treatment of iron overload due to repeated transfusions with subcutaneous infusions of desferrioxamine (author's transl)].
Girot R; Thévenin M; Bouveret JP; Jeannel F; Rymer JC
Arch Fr Pediatr; 1980 Apr; 37(4):241-7. PubMed ID: 7406638
[TBL] [Abstract][Full Text] [Related]
9. [Current status of treatments with desferrioxamine B in post-transfusion hypersiderosis in children].
Orsini A; Raybaud C; Bernard PJ; Aquaron R; Passeron P
Mars Med; 1967; 104(4):331-7. PubMed ID: 5621537
[No Abstract] [Full Text] [Related]
10. [Subcutaneous administration of deferoxamine in a patient with panmyelopathy and post-transfusion hemosiderosis].
Zdziarska B; Urasiński I
Pol Arch Med Wewn; 1987 Jul; 78(1):48-51. PubMed ID: 3271285
[No Abstract] [Full Text] [Related]
11. [Evaluation of iron balance in homozygous beta-thalassemia subjects treated with desferrioxamine administered subcutaneously].
Ferrara M; Galdo Capotorti M; Ponte G; Esposito L
Pediatria (Napoli); 1983; 91(4):371-7. PubMed ID: 6545400
[No Abstract] [Full Text] [Related]
12. Continuous high-dose intravenous desferrioxamine treatment for iron overload.
Sidi Y; Shaklai M; Liban E; Pinkhas J
Isr J Med Sci; 1981 May; 17(5):348-51. PubMed ID: 7263191
[TBL] [Abstract][Full Text] [Related]
13. [The effect of desferrioxamine on the treatment of transfusion hemosiderosis--with special reference to the method of its administration (authors' transl)].
Fujiyama N; Nakazawa K
Rinsho Ketsueki; 1977 Dec; 18(12):1393-400. PubMed ID: 604522
[No Abstract] [Full Text] [Related]
14. The treatment of Cooley's anemia.
Nathan DG
Haematologica; 1990; 75 Suppl 5():57-65. PubMed ID: 2086382
[No Abstract] [Full Text] [Related]
15. [Clinical and metabolic research on treatment with desferrioxamine B in various hemosiderotic erythrocyte diseases].
Cimino R; Quattrin N
Clin Ter; 1965 Jul; 34(1):3-32. PubMed ID: 5840761
[No Abstract] [Full Text] [Related]
16. [Effect of continuous subcutaneous infusion of deferoxamine in a boy with congenital hypoplastic anemia].
Ishitoya N; Gomibuchi I; Fujisawa K; Akatsuka J
Rinsho Ketsueki; 1988 Sep; 29(9):1408-12. PubMed ID: 3216512
[No Abstract] [Full Text] [Related]
17. Improvement in iron status and liver function in patients with transfusional iron overload with long-term subcutaneous desferrioxamine.
Hoffbrand AV; Gorman A; Laulicht M; Garidi M; Economidou J; Georgipoulou P; Hussain MA; Flynn DM
Lancet; 1979 May; 1(8123):947-9. PubMed ID: 87616
[TBL] [Abstract][Full Text] [Related]
18. [Use of desferal and some data on hemosiderosis in hypo- and aplastic anemias].
Fainshtein FE; Trubina NS; Sobaleva IuG; Rozanova NS; Voronina AN
Probl Gematol Pereliv Krovi; 1968 Aug; 13(8):31-8. PubMed ID: 5736846
[No Abstract] [Full Text] [Related]
19. [Long-term study in congenital refractory anemia and secondary siderosis].
Tuschy U; Schmidt U; Meinhold J; Wutke K
Z Gesamte Inn Med; 1982 Apr; 37(7):213-7. PubMed ID: 7102009
[TBL] [Abstract][Full Text] [Related]
20. [Long-term efficacy of subcutaneous administration of deferoxamine in patients with secondary hemochromatosis].
Kobayashi M; Yano K; Fujisawa S
Rinsho Ketsueki; 1996 Apr; 37(4):303-10. PubMed ID: 8847800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
